The original Cancer Drug Interactions website was a joint project between Radboud UMC and the University of Liverpool. Unfortunately the decision had to be made to take the site offline in September 2023 due to a lack of sustainable long-term funding to produce new content and keep the website up to date.
However, the University of Liverpool has been able to make an archived version of the interaction checker available to maintain a limited service. The content of the interaction checker was last updated in June 2022 and it is the responsibility of the user to assess the clinical relevance of the archived data and the risks and benefits of using such data. However, this service will be taken offline on 31st January 2025.
The University of Liverpool and its servants or agents shall not be responsible or in any way liable for the continued currency of information whether arising from negligence or otherwise howsoever or for any consequences arising therefrom. The University of Liverpool expressly exclude liability for errors, omissions or inaccuracies to the fullest extent permitted by law.
Please check our other resources for cancer therapy interactions with HIV drugs, hepatitis treatments and COVID-19 antivirals.
Alternatively, other checkers are available from third party providers, for example:
Please note the University of Liverpool has no involvement in these checkers, and this should not be construed as an endorsement of any third party application.
We would like to thank our sponsors for supporting this archived version of the interaction checker.